Ovarian reserve testing evaluates a woman's remaining egg supply and potential reproductive lifespan, helping to assess fertility and guide treatment decisions. It involves measuring biomarkers such as Anti-Müllerian Hormone (AMH) levels, antral follicle count (AFC), and follicle-stimulating hormone (FSH) levels during the early menstrual cycle phase.

Ovarian Reserve Testing

Remaining egg supply

Potential reproductive lifespan

Assess fertility

Treatment Decisions

Biomarkers are measurable indicators of biological processes, states, or conditions that can be used for diagnosis, prognosis, and monitoring of diseases. They play a crucial role in personalized medicine by enabling tailored treatment strategies based on individual biological profiles.

Biomarkers

Anti-Müllerian hormone (AMH) is a glycoprotein hormone that plays a crucial role in the regulation of folliculogenesis and serves as a marker of ovarian reserve in females. In males, it is involved in the regression of Müllerian ducts during fetal development, preventing the formation of female reproductive structures.

Anti-Müllerian Hormone

AMH Levels

Antral follicle count (AFC) is a transvaginal ultrasound test used to assess a woman's ovarian reserve by counting the visible follicles in the ovaries. It is a crucial indicator for evaluating fertility potential and planning assisted reproductive treatments such as IVF.

Antral Follicle Count

Follicle-stimulating hormone (FSH) is a crucial gonadotropin produced by the anterior pituitary gland that regulates the reproductive processes, including the maturation of ovarian follicles in females and spermatogenesis in males. Its levels are tightly regulated by the hypothalamic-pituitary-gonadal axis, influencing fertility and reproductive health.

Concepts

Relevant Degrees

Your Lessons